Harnessing the potential of multimodal radiotherapy in prostate cancer
Radiotherapy in combination with androgen deprivation therapy (ADT) is a standard treatment option for men with localized and locally advanced prostate cancer. However, emerging clinical evidence suggests that radiotherapy can be incorporated into multimodality therapy regimens beyond ADT, in combin...
Auteurs principaux: | Philippou, Y, Sjoberg, H, Lamb, AD, Camilleri, P, Bryant, RJ |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Springer Nature
2020
|
Documents similaires
-
Investigating tumour immune microenvironment effects of hypofractionated radiotherapy +/- immune checkpoint blockade in immunocompetent pre-clinical prostate cancer models
par: Y Philippou, et autres
Publié: (2020-07-01) -
8 Novel enhancement of multimodality treatment of prostate cancer, combining radiotherapy,vascular-targeted photodynamic therapy, and immunotherapy
par: H.T. Sjoberg, et autres
Publié: (2025-01-01) -
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
par: Philippou, Y, et autres
Publié: (2020) -
Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
par: Charlton, P, et autres
Publié: (2023) -
Harnessing the power of RNA in determining the origin of lethal micro-metastatic prostate cancer
par: A.M. Erickson, et autres
Publié: (2020-07-01)